Publication Name	World Journal of Gastroenterology
Manuscript ID	8040
Country	Italy

Received	2013-12-12 16:49
Peer-Review Started	2013-12-12 23:58
To Make the First Decision	2014-01-24 12:21
Return for Revision	2014-01-25 15:39
Revised	2014-02-09 00:32
Second Decision	2014-03-10 15:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-10 16:53
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-05-17 12:44
Publish the Manuscript Online	2014-06-06 16:55

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type	Observational Study
Article Title	Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis
Manuscript Source	Unsolicited Manuscript
All Author List	Giovanna Ferraioli, Carmine Tinelli, Raffaella Lissandrin, Mabel Zicchetti, Barbara Dal Bello, Gaetano Filice and Carlo Filice
Funding Agency and Grant Number	Funding Agency Grant Number Fibroscan device was made available for the study by Echosens (Paris, France)
Corresponding Author	Giovanna Ferraioli, MD, Researcher, Department of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Medical School University of Pavia, Via Taramelli 5, 27100 Pavia, Italy. giovanna.ferraioli@unipv.it
Key Words	Liver steatosis; Noninvasive techniques; Controlled attenuation parameter; Transient elastography; Chronic liver disease
Core Tip	A number of factors may affect response to treatment of patients with chronic viral hepatitis and it is well known that patients with liver steatosis are less responsive to antiviral drugs. On the other hand, early stages of liver steatosis are usually reversible with appropriate intervention. Controlled attenuation parameter (CAP) is a new method for non-invasive quantification of liver steatosis. The results of our study show that CAP is highly and significantly correlated with the extent of liver fat accumulation and it could be a useful tool in the clinical setting to diagnose the presence/absence of liver steatosis.
Publish Date	2014-06-06 16:55
Citation	Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, Filice C. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol 2014; 20(21): 6626-6631
URL	http://www.wjgnet.com/1007-9327/full/v20/i21/6626.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i21.6626

Full Article (PDF)	WJG-20-6626.pdf
Full Article (Word)	WJG-20-6626.doc
Manuscript File	8040-Review.doc
Answering Reviewers	8040-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20131212020631.pdf
Copyright License Agreement	8040-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	Ethics_Committee_20131212020559.docx
Non-Native Speakers of English Editing Certificate	8040-Language certificate.pdf
Peer-review Report	8040-Peer review(s).pdf
Scientific Editor Work List	8040-Scientific editor work list.doc